and prfA* (prfA G145S, NF-L1177), wildtype 10403S expressing actA-RFP (PL512) and wildtype and lmo2754::tn EGD-e were previously described.
Toxicity assays. J774 cells were incubated in 10 mM D-alanine, alkDala or azDala for 4 h and viability was assessed by ATP quantitation (CellTiter-Glo, Promega).
To assess bacterial viability in vivo, J774 cells were infected with L.
monocytogenes at a multiplicity of infection of 5. After 30 min, the coculture was rinsed in PBS then incubated in fresh DMEM medium containing 10 mM D-alanine, alkDala or azDala for 3.5 h. Gentamicin was added 30 min after addition of D-alanine derivatives. Cells were rinsed in PBS then lysed in PBS + 0.2% Triton-X for 5 min at 4 °C. Serial dilutions of the lysate were spotted on LB plates and incubated at 37 °C overnight prior to enumeration.
To test for strain-promoted cycloaddition toxicity, C. glutamicum was treated with 5 mM D-alanine or azDala for 90 min then washed and incubated in PBS containing 10 μM DIFO-488 at RT. After 30 min, serial dilutions of bacteria were spotted on LB plates and incubated at 30 °C overnight prior to enumeration.
Microscopy. Labeled bacteria were imaged live or after fixation. After washing in PBS, the cells were either resuspended in PBS or air dried and mounted in Vectashield (Vector Labs) and imaged on a glass coverslip using a Zeiss Axiovert 200M inverted microscope equipped with a 100x/1.30 Plan-Neofluar oil immersion lens. Image stacks were acquired using a CoolSNAP HQ charged-coupled device camera (Roper Scientific).
Flow cytometry. Triplicate samples of labeled bacteria were washed in PBS and resuspended to a final volume of 400 µL. Flow cytometry was performed on a BD Biosciences FACSCalibur instrument. Between 50,000-100,000 cells were analyzed for each sample and the mean fluorescence intensities for ungated samples were plotted in arbitrary units.
High performance liquid chromatography and mass spectrometry. E. coli and L. monocytogenes were grown overnight in 150 or 50 mL of medium, respectively, containing 5 mM D-alanine or D-alanine analog. Bacteria were washed in PBS then reacted with reacted with azido-fluor 488 for 1 h. PG from labeled cells was purified by the boiling SDS extraction method and muramidase digestion treatment (Cellosyl) as previously described.(6) Solubilized muropeptides were then either directly injected into the HPLC system (non-reduced samples) or subjected to sodium borohydride reduction as described previously.(6) Muropeptides were analyzed using a binary-pump Waters HPLC system (Waters Corporation, Milford, USA) fitted with a reverse phase RP18 Aeris peptide column (250 x 4.6 mm; 3.6 µm particle size) (Phenomenex, USA) and a dual wavelength absorbance detector. Elution conditions were: flow rate 1 mL/min; temperature 35 ºC; 3 min isocratic elution in 50 mM sodium phosphate, pH 
